LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.
Popular Links
Any Questions?
For more information about FCI offer or to get in touch with your local distributor,
please contact us. We will be in touch with you shortly.